Crenolanib for treating flt3 mutated proliferative disorders

Crenolanib for treating flt3 mutated proliferative disorders

  • CN 105,555,272 A
  • Filed: 10/14/2013
  • Published: 05/04/2016
  • Est. Priority Date: 01/07/2013
  • Status: Active Application
First Claim
Patent Images

1. treat a FLT3 saltant type proliferative disease patient'"'"'s method, comprise the crenolanib or the acceptable salt of its pharmacy that give a kind of dose therapeutically effective of patient.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×